A Dallas federal jury delivered a $502 million verdict against Johnson & Johnson and one of its subsidiaries. The jury issued the decision March 17 after a nine-week trial and one week of deliberations.
At the trial, eight plaintiffs had claimed damages related to the companies’ hip-replacement devices. More than 4,000 other plaintiffs have filed similar claims, which are pending in multidistrict litigation (MDL) in the U.S. District Court for the Northern District of Texas in Dallas.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
